genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2009
miRNA (Gene therapy)
Insights
Chasing the Therapeutic Potential of miRNAs
Cancer
Prometheus Gains U.S. Rights to Rosetta’s Cancer Tests
Insights
Gov’t Actions Buoy European Start-Ups
Insights
New and Old Technologies Boost Advances
News
Mirna and UCSF Ally to Explore Therapeutic Potential of miRNAs
News
Researchers Figure Out that Too Much Lamin Leads to Myelin Failure
News
Rosetta Launches Second miRNA Diagnostic for Cancers of Unknown Primary
Insights
Applicability of Biomarkers Is Far-Reaching
News
Regulus Therapeutics Spun Out of Isis and Alnylam to Focus on miRNA Drugs
1
...
5
6
7
Page 7 of 7
Scroll Up
Scroll Up
